DIA, India organises ’IT Life Sciences Summit 2012: Technology Enabled Pharmaceutical…
Participants were from Life Sciences, Contract Research Organisations (CROs), and Information Technology product and services…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
‘Mylan can set a new standard in the treatment of HIV/AIDS in India’
Mylan recently started commercial operations in India with the launch of 18 ARVs, including heat stable, combination, and…
ICDR rules in favour of Glenmark wins ruling to commercialise, distribute Crofelemer
The International Centre for Dispute Resolution (ICDR) ruled in favour of Glenmark on the arbitration claim it filed on August 8,…
India, Sri Lanka to jointly fund pharma hub
Sri Lankan pharma hub to be ready in the next two years, Pharmexcil to promote exports from India
Report on CDSCO functioning to be ready in three months
DCGI mulls rule to protect patients enrolled in clinical trials
Phase I trial of CSIR-IMTECH’s clot buster to start by end October
Ahmedabad’s Veeda CR to conduct the trial, CSIR aims to launch drug in India by 2014
Merck acquires Biochrom
The acquisition will strengthen Merck Millipore’s Process Solutions business unit
Wockhardt gets US FDA approval for generic version of anti-hypertensive drug Plendil
Will manufacture the felodipine API in its facility at Ankleshwar
Venus Remedies launches Trois for arthritic pain
Trois is a patent protected topical nano emulsion with all natural ingredients and has no side effects
IPAB postpones hearing on Natco’s CL for Bayer’s Nexavar to Sept 3
Focus shifts to Novartis India's challenge to Section 3 (d), scheduled for tomorrow
US FDA clears Claris Lifesciences’ facility after remedial action
Approval allows Claris to re-enter US market
‘It is a critical time to capitalise on the biotech opportunities available within…
James C Greenwood, President and CEO, Biotechnology Industry Organisation (BIO) and a former Congressman from Pennsylvania, US…
CPhI Worldwide 2012 to raise success story of Indian pharma industry
Event to be held in Feria de Madrid, Spain from October 9 to 11, 2012
A clarion call to step up research for AIDS vaccine
India renews its commitment towards collaborative HIV vaccine research: DBT and IAVI set up a new lab devoted to the same
Gearing up for the biosimilar boom
Viveka Roychowdhury seeks reactions of industry players to DBT's draft biosimilar guidelines and analyses whether it can serve as…
DCGI asks CDSCOs offices to ensure implementation of ban on serodiagnostic test kits
Post the ban on serodiagnostic test kits, the Drug Controller General (India) (DCGI) has requested zonal, sub zonal, port offices…
M&A activity in the pharma sector decreases in both volume and value terms
The pharma sector recorded 27 M&A transactions in July 2012, against the previous six months’ average of 49 transactions
Pharmexcil and MHLW, Japan to promote generic drugs
Invites Indian pharma players to supply drugs at affordable price
CDSCO calls for suggestions on draft guidelines for compensating clinical trial victims
Recommendations to be submitted before September 2, 2012
Commerce Ministry to discuss issues on non-tariff barriers in pharma industry with US and EU
Pharma industry to form committee of all industry representatives